SDIC
VIVO

South Dakota Investment Council’s Meridian Bioscience Inc VIVO Stock Holding History

South Dakota Investment Council’s Portfolio VIVO Stock Details VIVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-34,363
Closed -$1.14M – 635
2022
Q4 		$1.14M Hold
34,363
– – 0.03% 437
2022
Q3 		$1.08M Hold
34,363
– – 0.03% 422
2022
Q2 		$1.04M Hold
34,363
– – 0.02% 430
2022
Q1 		$892K Sell
34,363
-8,100
-19% -$193K 0.02% 456
2021
Q4 		$866K Hold
42,463
– – 0.01% 491
2021
Q3 		$817K Hold
42,463
– – 0.01% 486
2021
Q2 		$942K Buy
42,463
+2,010
+5% +$42.6K 0.02% 479
2021
Q1 		$1.06M Buy
40,453
+353
+0.9% +$8.39K 0.02% 471
2020
Q4 		$749K Hold
40,100
– – 0.01% 484
2020
Q3 		$681K Hold
40,100
– – 0.01% 459
2020
Q2 		$934K Hold
40,100
– – 0.02% 410
2020
Q1 		$337K Buy
40,100
+21,000
+110% +$177K 0.01% 486
2019
Q4 		$187K Hold
19,100
– – ﹤0.01% 549
2019
Q3 		$181K Buy
+19,100
New +$201K ﹤0.01% 579

Other funds holding VIVO

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

South Dakota Investment Council's VIVO Position: Q1 2023 in Review

South Dakota Investment Council sold out of Meridian Bioscience Inc (VIVO) in Q1 2023, closing a stake of 34,363 shares — an estimated $1.14M sold.

South Dakota Investment Council first reported a position in VIVO in Q3 2019 and held it in 14 quarters. The position peaked at $1.14M in Q4 2022. 2 funds tracked by Wall St. Rank hold VIVO as of Q1 2023.

  • South Dakota Investment Council reported no remaining Meridian Bioscience Inc position as of Q1 2023 after selling out during the quarter.
  • South Dakota Investment Council sold 34,363 Meridian Bioscience Inc shares in Q1 2023, an estimated $1.14M.
  • South Dakota Investment Council first reported a position in Meridian Bioscience Inc in Q3 2019 and held it in 14 quarters.
  • South Dakota Investment Council's Meridian Bioscience Inc position peaked at $1.14M in Q4 2022.
  • 2 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q1 2023.

Based on South Dakota Investment Council's 13F filing for Q1 2023, filed 10 May 2023.